Alterity Therapeutics Stock Technical Analysis

ATHE Stock  USD 1.87  0.01  0.53%   
As of the 31st of May, Alterity Therapeutics shows the Risk Adjusted Performance of 0.0262, mean deviation of 4.6, and Downside Deviation of 6.86. Alterity Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyze and collected data for nineteen technical drivers for Alterity Therapeutics, which can be compared to its peers. Please confirm Alterity Therapeutics treynor ratio, as well as the relationship between the potential upside and expected short fall to decide if Alterity Therapeutics is priced correctly, providing market reflects its regular price of 1.87 per share. Please also double-check Alterity Therapeutics total risk alpha, which is currently at 0.0294 to validate the company can sustain itself at a future point.

Alterity Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Alterity, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Alterity
  
Alterity Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Alterity Therapeutics Analyst Consensus

Target PriceAdvice# of Analysts
25.0Strong Buy2Odds
Alterity Therapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Alterity analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Alterity stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Alterity Therapeutics, talking to its executives and customers, or listening to Alterity conference calls.
Alterity Analyst Advice Details
Alterity Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Alterity Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Alterity Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Alterity Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Alterity Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Alterity Therapeutics Trend Analysis

Use this graph to draw trend lines for Alterity Therapeutics. You can use it to identify possible trend reversals for Alterity Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Alterity Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Alterity Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Alterity Therapeutics applied against its price change over selected period. The best fit line has a slop of    , which means Alterity Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.94, which is the sum of squared deviations for the predicted Alterity Therapeutics price change compared to its average price change.

About Alterity Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Alterity Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Alterity Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Alterity Therapeutics price pattern first instead of the macroeconomic environment surrounding Alterity Therapeutics. By analyzing Alterity Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Alterity Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Alterity Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 (projected)
Net Debt To EBITDA1.181.75
Intangibles To Total Assets0.320.3

Alterity Therapeutics May 31, 2024 Technical Indicators

Most technical analysis of Alterity help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Alterity from various momentum indicators to cycle indicators. When you analyze Alterity charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Alterity Therapeutics May 31, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Alterity stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Alterity Therapeutics is a strong investment it is important to analyze Alterity Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Alterity Therapeutics' future performance. For an informed investment choice regarding Alterity Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alterity Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
For information on how to trade Alterity Stock refer to our How to Trade Alterity Stock guide.
Note that the Alterity Therapeutics information on this page should be used as a complementary analysis to other Alterity Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Alterity Stock analysis

When running Alterity Therapeutics' price analysis, check to measure Alterity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterity Therapeutics is operating at the current time. Most of Alterity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alterity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterity Therapeutics' price. Additionally, you may evaluate how the addition of Alterity Therapeutics to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Is Alterity Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alterity Therapeutics. If investors know Alterity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alterity Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.75)
Revenue Per Share
0.6
Quarterly Revenue Growth
(0.20)
Return On Assets
(0.29)
Return On Equity
(0.54)
The market value of Alterity Therapeutics is measured differently than its book value, which is the value of Alterity that is recorded on the company's balance sheet. Investors also form their own opinion of Alterity Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Alterity Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alterity Therapeutics' market value can be influenced by many factors that don't directly affect Alterity Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alterity Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alterity Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alterity Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.